RAMPART: A phase III multi-arm multi-stage trial of adjuvant checkpoint inhibitors in patients with resected primary renal cell carcinoma (RCC) at high or intermediate risk of relapse (2021)

First Author: Oza B
Attributed to:  Design of Trials, Meta-analyses and observational studies funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1016/j.cct.2021.106482

Publication URI: http://dx.doi.org/10.1016/j.cct.2021.106482

Type: Journal Article/Review

Parent Publication: Contemporary Clinical Trials

ISSN: 1551-7144